Business Description
Redcare Pharmacy NV
ISIN : NL0012044747
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.86 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 5.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 5.81 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.6 | |||||
3-Year EBITDA Growth Rate | 51.8 | |||||
3-Year EPS without NRI Growth Rate | -3.7 | |||||
3-Year Book Growth Rate | 3.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 24.95 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 8.86 | |||||
9-Day RSI | 19.97 | |||||
14-Day RSI | 29 | |||||
6-1 Month Momentum % | 14.64 | |||||
12-1 Month Momentum % | 6.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.12 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.86 | |||||
Days Inventory | 28.81 | |||||
Days Sales Outstanding | 17.73 | |||||
Days Payable | 35.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | 0.22 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.2 | |||||
Operating Margin % | -0.96 | |||||
Net Margin % | -1.1 | |||||
FCF Margin % | -0.47 | |||||
ROE % | -4.76 | |||||
ROA % | -2.37 | |||||
ROIC % | -3.01 | |||||
ROC (Joel Greenblatt) % | -13.86 | |||||
ROCE % | -2.57 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 960.12 | |||||
PS Ratio | 1.22 | |||||
PB Ratio | 5.38 | |||||
Price-to-Tangible-Book | 29.82 | |||||
Price-to-Operating-Cash-Flow | 87.84 | |||||
EV-to-EBIT | -134.12 | |||||
EV-to-Forward-EBIT | 111.3 | |||||
EV-to-EBITDA | 56.96 | |||||
EV-to-Forward-EBITDA | 37.16 | |||||
EV-to-Revenue | 1.24 | |||||
EV-to-Forward-Revenue | 1 | |||||
EV-to-FCF | -261.8 | |||||
Price-to-Projected-FCF | 126.2 | |||||
Price-to-Net-Current-Asset-Value | 1135.83 | |||||
Earnings Yield (Greenblatt) % | -0.75 | |||||
FCF Yield % | -0.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Redcare Pharmacy NV Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2,226.756 | ||
EPS (TTM) (€) | -1.232 | ||
Beta | 1.08 | ||
Volatility % | 21.78 | ||
14-Day RSI | 29 | ||
14-Day ATR (€) | 2.343768 | ||
20-Day SMA (€) | 149.26 | ||
12-1 Month Momentum % | 6.62 | ||
52-Week Range (€) | 117.4 - 163.15 | ||
Shares Outstanding (Mil) | 20.02 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Redcare Pharmacy NV Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Redcare Pharmacy NV Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Redcare Pharmacy NV Frequently Asked Questions
What is Redcare Pharmacy NV(CHIX:RDCd)'s stock price today?
When is next earnings date of Redcare Pharmacy NV(CHIX:RDCd)?
Does Redcare Pharmacy NV(CHIX:RDCd) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |